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Abstract: Thiosulfate formation and biodegradation processes link aerobic and anaerobic metabolism
of cysteine. In these reactions, sulfite formed from thiosulfate is oxidized to sulfate while hydrogen
sulfide is transformed into thiosulfate. These processes occurring mostly in mitochondria are described
as a canonical hydrogen sulfide oxidation pathway. In this review, we discuss the current state
of knowledge on the interactions between hydrogen sulfide and hemoglobin, myoglobin and
neuroglobin and postulate that thiosulfate is a metabolically important product of this processes.
Hydrogen sulfide oxidation by ferric hemoglobin, myoglobin and neuroglobin has been defined as
a non-canonical hydrogen sulfide oxidation pathway. Until recently, it appeared that the goal of
thiosulfate production was to delay irreversible oxidation of hydrogen sulfide to sulfate excreted
in urine; while thiosulfate itself was only an intermediate, transient metabolite on the hydrogen
sulfide oxidation pathway. In the light of data presented in this paper, it seems that thiosulfate
is a molecule that plays a prominent role in the human body. Thus, we hope that all these findings
will encourage further studies on the role of hemoproteins in the formation of this undoubtedly
fascinating molecule and on the mechanisms responsible for its biological activity in the human body.
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1. Introduction
Cysteine is the main source of sulfur in the animal and human body. It is metabolized via
two pathways. The first one, called the cysteinesulfinate-dependent (aerobic) pathway, is a series
of processes leading to taurine and inorganic sulfate (SO42−). The second path is independent of
cysteinesulfinate (anaerobic) and is a source of sulfane sulfur-containing compounds and hydrogen
sulfide/sulfide (H2S/S2−) (Figure 1). In general, sulfur metabolism in animals consists in its oxidation
to the highest +6 oxidation state. Thus, SO42− can be considered the final product of sulfur metabolism
in animals. The sulfane sulfur is a labile reactive sulfur atom in the 0 or –1 oxidation state, covalently
bound to another sulfur atom which can easily leave the structure of the compound and can readily
react with various acceptors, such as reduced glutathione (GSH) and other thiols (RSH) or cyanide
(CN−) [1–3] (Figure 2). Some other compounds, such as the outer sulfur atom of thiosulfate (S=SO32−)
and elemental sulfur (S8), also possess properties characteristic of sulfane sulfur [4]. In the literature,
aside from sulfane sulfur, the term “bound sulfur” is also used. This term describes sulfur that can
be released as H2S by reducing agents, such as dithiothreitol (DTT) [5–7]. It is believed that “bound
sulfur” can be a fraction of sulfane sulfur [4].
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Figure 1. Two L-cysteine transformation pathways: the aerobic path leads to taurine and sulfate, while 
the anaerobic route to sulfane sulfur-containing compounds and hydrogen sulfide. CSE: cystathionine 
γ-lyase; CAT: cysteine aminotransferase; 3-MST: 3-mercaptopyruvate sulfurtransferase; TRX: 
thioredoxin; DTT: dithiothreitol. 
In 1996, hydrogen sulfide (H2S) was first evidenced to be produced endogenously in mammalian 
tissues, suggesting that it could have physiological functions [8]. It is synthesized from L-cysteine by 
cystathionine γ-lyase (EC 4.4.1.1; CSE) and cysteine aminotransferase (EC 2.6.1.3; CAT) in cooperation 
with 3-mercaptopyruvate sulfurtransferase (EC 2.8.1.2; 3-MST) [9]. H2S has a half-life in vivo of several 
minutes [10]. It is currently known that H2S is an important biological messenger molecule that 
transmits signals by forming persulfide bonds (SSH) in proteins or in low-molecular thiols [11–13]. In 
this context, it is interesting to look at sulfide:quinone oxidoreductase (EC 1.8.5.4; SQR) involved in 
mitochondrial H2S oxidation. This enzyme catalyzes a two-electron oxidation of H2S to the sulfane 
sulfur containing persulfide SQR-SSH. This sulfane sulfur is then transferred onto different 
nucleophilic acceptors, including reduced glutathione (GSH), which is transformed into glutathione 
persulfide (GSSH). The sulfur of GSSH may by then oxidized to sulfite by ethylmalonic 
encephalopathy protein 1 (EC 1.13.11.20; ETHE1) or transferred to sulfite (SO32−) by rhodanese (EC 
2.8.1.1; thiosulfate:cyanide sulfurtransferase, TST) to form thiosulfate (Figure 2). Thus, thiosulfate is 
formed as a result of reaction between intermediates of two metabolic routes, namely sulfite and 
sulfide. Sulfite is further oxidized to sulfate by sulfite oxidase (EC 1.8.3.1; SO), whereas thiosulfate may 
be converted back to H2S and sulfite by thiosulfate reductase (EC 2.8.1.3; TR) [14–17]. It appears that 
thiosulfate may be considered as a safe nontoxic storage form of H2S in the body. The unconventional 
experiments by Koj and Frendo [18], Koj et al. [19] and Skarżyński et al. [20] clearly demonstrated a 
central role of thiosulfate as a key intermediate in the H2S metabolism. 
It seems that thiosulfate production can delay irreversible H2S oxidation to SO42− excreted in urine. 
These processes occurring in mitochondria are termed a canonical H2S oxidation pathway. However, 
recently new chemical interactions between H2S and hemoproteins have been described which yield 
thiosulfate and iron-bound hydropersulfides. This process is called a non-canonical H2S oxidation 
pathway [21]. Although it has been mostly examined in relation to H2S detoxification, the thiosulfate 
formation as a biologically important molecule appears to be the essence of this process. Therefore, 
looking at H2S catabolism engaging hemoproteins in this context is interesting and inspiring but it has 
still received little attention. 
Figure 1. Two L-cysteine transformation pathways: the aerobic path leads to taurine and
sulfate, while the anaerobic route to sulfane sulfur-containing compounds and hydrogen sulfide.
CSE: cystathionine γ-lyase; CAT: cysteine aminotransferase; 3-MST: 3-mercaptopyruvate
sulfurtransferase; TRX: thioredoxin; DTT: dithiothreitol.
In 1996, hydrogen sulfide (H2S) was first evidenced to be produced endogenously in mammalian
tissues, suggesting that it could have physiological functions [8]. It is synthesized from L-cysteine by
cystathionine γ-lyase (EC 4.4.1.1; CSE) and cysteine aminotransferase (EC 2.6.1.3; CAT) in cooperation
with 3-mercaptopyruvate sulfurtransferase (EC 2.8.1.2; 3-MST) [9]. H2S has a half-life in vivo of several
minutes [10]. It is currently known that H2S is an important biological messenger molecule that
transmits signals by forming persulfide bonds (SSH) in proteins or in low-molecular thiols [11–13].
In this context, it is interesting to look at sulfide:quinone oxidoreductase (EC 1.8.5.4; SQR) involved
in mitochondrial H2S oxidation. This enzyme catalyzes a two-electron oxidation of H2S to the sulfane
sulfur containing persulfide SQR-SSH. This sulfane sulfur is then transferred onto different nucleophilic
acceptors, including reduced glutathione (GSH), which is transformed into glutathione persulfide
(GSSH). The sulfur of GSSH may by then oxidized to sulfite by ethylmalonic encephalopathy protein 1
(EC 1.13.11.20; ETHE1) or transferred to sulfite (SO32−) by rhodanese (EC 2.8.1.1; thiosulfate:cyanide
sulfurtransferase, TST) to form thiosulfate (Figure 2). Thus, thiosulfate is formed as a result of reaction
between intermediates of two metabolic routes, namely sulfite and sulfide. Sulfite is further oxidized
to sulfate by sulfite oxidase (EC 1.8.3.1; SO), whereas thiosulfate may be converted back to H2S and
sulfite by thiosulfate reductase (EC 2.8.1.3; TR) [14–17]. It appears that thiosulfate may be considered
as a safe nontoxic storage form of H2S in the body. The unconventional experiments by Koj and
Frendo [18], Koj et al. [19] and Skarżyński et al. [20] clearly demonstrated a central role of thiosulfate
as a key intermediate in the H2S metabolism.
It seems that thiosulfate production can delay irreversible H2S oxidation to SO42− excreted
in urine. These processes occurring in mitochondria are termed a canonical H2S oxidation pathway.
However, recently new chemical interactions between H2S and hemoproteins have been described
which yield thiosulfate and iron-bound hydropersulfides. This process is called a non-canonical H2S
oxidation pathway [21]. Although it has been mostly examined in relation to H2S detoxification,
the thiosulfate formation as a biologically important molecule appears to be the essence of this process.
Therefore, looking at H2S catabolism engaging hemoproteins in this context is interesting and inspiring
but it has still received little attention.
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Figure 2. The thiosulfate cycle links aerobic and anaerobic metabolism of cysteine. H2S can be oxidized 
by SQR and ETHE1 to thiosulfate. Sulfane sulfur can be transferred from GSSH to sulfite leading to 
thiosulfate formation. Sulfite can also be further oxidized to sulfate by SO. On the other hand, 
thiosulfate may be converted back to H2S and sulfite by TR. SO: sulfite oxidase; ETHE1: ethylmalonic 
encephalopathy protein 1; TST: rhodanese; TR: thiosulfate reductase; SQR: sulfide:quinone 
oxidoreductase. 
The aim of the present work was to briefly recapitulate the current state of knowledge on 
interrelationships between H2S and hemoproteins: hemoglobin (Hb), myoglobin (Mb) and neuroglobin 
(Ngb) and to highlight a potential biological significance of thiosulfate as a direct product of H2S 
oxidation by hemoproteins. 
2. Red Blood Cells, Hemoglobin and Hydrogen Sulfide 
Hemoglobin of adults (HbA) is a hematoporphyrin built of four polypeptide chains (two α and 
two β). The α chain is composed of 141 amino acids while the β chain of 146 amino acids. Each chain 
binds one heme molecule. The main function of hemoglobin consists in oxygen transport from the 
lungs to the tissues. One Hb molecule can bind four oxygen molecules. Thanks to Hb, oxygen carrying 
capacity of one liter of blood is 250 mL of oxygen while without Hb one liter of blood could transport 
only 5 mL of oxygen. Hb also participates in carbon dioxide (CO2) transport from tissues to the lungs, 
carrying ca. 60% of the total amount of CO2 exchanged by red blood cells (RBCs) during breathing. 
Moreover, Hb is the most important transport protein of nitric oxide (NO). Hb exhibits the greatest 
affinity for NO in relaxed (R) conformation i.e. during full oxidation. 
Under physiological conditions, the reduced form called deoxyhemoglobin (deoxyHb) binds 
oxygen in the lungs and is transformed into oxyhemoglobin (oxyHb) which alters oxidation state of the 
centrally located ferrous ion (Fe2+). OxyHb is a stable form but under physiological conditions even 3% 
of oxyHb per 24 h is oxidized to methemoglobin (ferric hemoglobin, MetHb) in which centrally located 
iron is in the +3 oxidation state (Fe3+) [22]. MetHb is unable to transport oxygen and CO2. Hb 
participates also in many other physiological processes. It is not an enzyme but shows 
pseudoenzymatic activity of catalase, peroxidase, monooxygenase and esterase, and also O- and 
N-demethylase [23,24]. The presence of 3-MST in RBCs, which is an enzyme engaged in the formation 
and transport of sulfane sulfur and H2S (Figure 1) and the fact that these cells do not contain 
mitochondria which house the canonical H2S oxidation machinery, suggest that Hb can be also 
responsible for maintaining H2S and sulfane sulfur homeostasis in the circulatory system. The reaction 
of H2S with Hb to produce sulfheme derivatives is commonly known and involves the covalent 
addition of sulfide to one of the pyrrole rings [25]. Sulfhemoglobin (SulfHb) is a green-pigmented 
molecule containing a sulfur atom in one or more of the porphyrin rings. Normally, SulfHb is not 
present in the blood, and its levels greater than 60% can lead to death due to tissue hypoxia. 
Sulfhemoglobinemia is a hematological condition accompanying treatment with some drugs, including 
Figure 2. T e thiosulfate cycle links aerobic and anaerobic metabolism of cysteine. H2S can
be oxidized by SQR and ETHE1 to thios lfate. Sulfane sulfur can be transferred from GSSH
t sulfite leading to thiosulfate formation. Sulfite can also be further oxidized to sulfate by SO.
On the other hand, thiosulfate may be co verted back to H2S and sulfite by TR. SO: sulfite oxidase;
ETHE1: ethylmalonic encephalopathy protein 1; TST: rhodanese; TR: thiosulfate r ductase;
SQR: sulfide:quinone oxidoreductase.
The aim of the present work was to briefly recapitulate the current state of knowledge on
interrelationships between H2S and hemoproteins: hemoglobin (Hb), myoglobin (Mb) and neuroglobin
(Ngb) and to highlight a potential biological significance of thiosulfate as a direct product of H2S
oxidation by hemoproteins.
2. Red Blood Cells, Hemoglobin and Hydrogen Sulfide
Hemoglobin of adults (HbA) is a he atoporphyrin built f f l ti i (t o α and
two β). The α chain is composed of 141 amino acids il t i f i acids. Each chain
binds one heme molecule. The main function of hem globin con ists in oxygen transpo t from
the lungs to the tissu s. One Hb molecule can bind four oxyg n molecules. Thanks to Hb, oxygen
carrying capacity of one liter of blood is 250 mL of oxygen while without Hb one liter of blood could
transport only 5 mL of oxygen. Hb also participates in carbon dioxide (CO2) transport from tissues to
the lungs, carrying ca. 60% of the total amount of CO2 exchanged by r d blood cells (RBCs) duri
br athing. Moreover, Hb is the most important transport protein of nitric oxid (NO). Hb exhibit
the greatest affinity for NO in relaxed (R) conformation i.e. during full oxidation.
Under physi logical conditions, the reduced f r ll e x l i (deoxy b) binds
oxygen in the lungs and is transformed into oxyhemoglobin (oxyHb) w ich alters oxidation state of
the centrally located ferrous ion (Fe2+). OxyHb is a stable form but under physiol gical conditions
even 3% of oxyHb per 24 h is oxidized to methemoglobin (ferric hemoglobin, MetHb) in which
centrally located iron is i the +3 oxidation state (Fe3+) [22]. MetHb is unable to transport oxygen
and CO2. Hb particip tes also in many other physiological processes. It is not an enzyme but
shows pseudoenzymatic activity of catalase, p roxidase, mo ooxygenase and esterase, and also
O- and N-d methylase [23,24]. The presence of 3-MST in RBCs, which is n enzym engaged
in the formation and transport of sulfane sulfur and H2S (Figure 1) and the fact that these cells
d n t contain mitochondria which house the canonical H2S oxidation machinery, suggest that
Hb can be also respo sible for maintai ing H2S and sulf ne sulfur homeostasis in the circul tory
system. The reaction of H2S with Hb to produce sulfhe e derivatives is commonly known nd
involves the covalent addition of sulfide to one of the pyrrole rings [25]. Sulfhemoglobin (SulfHb)
is a green-pigmented molecule co taining a sulfur atom in one or more of the porphyrin rings.
Normally, SulfHb is not present in the blood, and its levels greater than 60% can lead to death
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due to tissue hypoxia. Sulfhemoglobinemia is a hematological condition accompanying treatment
with some drugs, including co-trimoxazole, phenacetin, phenazopyridine and metoclopramide [26].
Sulfhemoglobinemia can also result from the presence of H2S-producing bacteria in the intestine [27].
Recently, a case of sulfhemoglobinemia was described in a child with chronic constipation and urinary
tract infection [27].
In adults, Hb concentration in the whole blood averages 2.3 mM while a mean corpuscular
Hb concentration (MCHC) is ca. 5.3 mmol/L RBCs. MetHb accounts for 1–3% of the total Hb,
and its concentration in the whole blood is 25–75 µM (corresponding to 100–300 µM ferric heme) and
53–159 µM in 1 liter of RBCs (corresponding to 212–636 µM ferric heme), respectively. Considering
that RBCs occupy ca. 40–50% of blood volume, it is obvious that MetHb plays a significant role in H2S
oxidation. Literature data demonstrated that ca. 3 moles of H2S were inactivated by one mole of
MetHb [28]. However, data on the concentration of H2S in human plasma and tissues are equivocal.
Olson underlined that the reports of 2001–2009 indicated its high concentration in the body, estimated
even at 300 µM, while since 2010 a majority of studies revealed a much lower concentration [29].
At present, it is believed that the true free H2S concentration in human plasma and tissues is in low
micromolar or even nanomolar range [9].
H2S differs from other gasotransmitters (NO and CO) in its ability to dissociate. Its pKa1 is 6.89,
and pKa2 is 19.0 and in physiological conditions, i.e. at pH 7.4 in aqueous solutions, 20% of hydrogen
sulfide remains undissociated and 80% is dissociated to HS− anion while S2− anion concentration
is extremely low. The rate constant for H2S binding to ferric Hb (FeIII-Hb) increases with decreasing
pH [21,30,31]. This fact suggests that H2S rather than more abundant HS− anion initially interacts
with MetHb. The course of this process was described by Vitvitsky et al. [32]. As presented in Figure 3,
H2S is oxidized by MetHb to form thiosulfate and hydropolysulfie.
3. Properties of Myoglobin and Its Interaction with Hydrogen Sulfide
Mb is a monomeric heme protein found in most animal muscles in a concentration of 0.5–1%
by weight [33]. It contains one heme group per protein molecule. Molecular weight of human
Mb is ca. 17,800 Da. Similar to Hb, Mb is a cytoplasmic protein that binds oxygen on a heme
group. Although heme groups of both proteins are identical, Mb has a higher affinity for oxygen
than Hb. The partial pressure of oxygen (pO2) in the blood, at which Hb saturation is 50% (P50),
is about 26 mmHg for a healthy person, while Mb reaches 50% saturation already at pO2 = 1 mmHg.
This difference is related to its different role: whereas Hb transports oxygen, Mb function is to store
oxygen and release it during periods of its deprivation in muscle tissues. Similar to Hb, Mb occurs
in the body in three characteristic physiological forms: oxyMb and deoxyMb, in which centrally
located iron is in the +2 oxidation state (Fe2+) and ferric Mb (MetMb), in which centrally located iron
is in the +3 oxidation state (Fe3+).
Mb was the first protein whose 3D structure was revealed using X-ray crystallography [34].
The amino acids sequence identity between the α-chain, β-chain of Hb and the chain of Mb
is approximately 12%. Thus, it is quite unexpected that the tertiary structures of all three polypeptide
chains are surprisingly similar [35,36]. It means that very different amino acid sequences can encode
truly similar spatial structures determining biological function of proteins.
Therefore, it is not surprising that, similar to in the case of MetHb, an interaction between MetMb
and H2S that leads to catalytic turnover of H2S has been discovered [21]. It was also demonstrated
that whale sperm MetMb bound H2S in vitro (KD = 18.5 µM at pH 7.5, at a temperature of 20 ◦C) [37],
similar to human MetHb (KD = 17 µM at pH 7.4, at a temperature of 37 ◦C) [38]. The transformation
of H2S by MetMb is similar to that of MetHb and also leads to the formation of thiosulfate and
hydropolysulfide [38] (Figure 3).
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Figure 3. A schematic representation of the postulated mechanism for the MetHb and MetMb-dependent 
oxidation of H2S to thiosulfate and heme iron-bound persulfides. Modified from Vitvitsky et al. [21] and 
Bostelaar et al. [38]. 
4. Interactions of Neuroglobin with Hydrogen Sulfide 
Ngb is a member of the hemoprotein family which is expressed in the brain, mostly in the 
subthalamic nucleus, frontal lobe, thalamus and occipital pole [35]. Ngb was also identified in other 
tissues, such as the gastrointestinal tract, lungs, some endocrine tissues, spinal cord, lymph nodes and 
in the peripheral nervous system [39–41]. It has been demonstrated that Ngb is the third protein, 
besides Hb and Mb, reversibly binding oxygen via the Fe2+ ion of the heme group in humans and other 
vertebrates [39,42]. Ngb is a six-coordinate hemoprotein, with the heme iron coordinated by two 
histidine residues. In terms of physicochemical properties, Ngb shows a greater similarity to Mb 
because it is a monomer with molecular weight of 17,000 Da composed of 151 amino acids and 
characterized by a high affinity for oxygen (half saturation pressure, P50 = 1–2 mmHg at 37 °C) [42]. 
Hence, it can be concluded that Ngb is analogous to Mb. However, Ngb shares little amino-acid 
sequence similarity with Mb (<21% identity) [39]. Ngb displays also a modest sequence homology with 
Hb (<25% identity) [39]. The physiological role of Ngb is still elusive. Currently, it is assumed that Ngb 
is an endogenous neuroprotective protein, active against several brain injuries, including hypoxia, 
ischemia, toxicity, and oxygen/nutrient deprivation [43]. In vitro studies showed that H2S bound very 
tightly to the heme group of human ferric Ngb (MetNgb). The bimolecular rate constant for H2S 
binding to MetNgb was about 35 and 1000 fold slower than for MetHb and MetMb, respectively [30]. 
Ruetz et al. [44] observed that H2S oxidation to sulfate and thiosulfate in the brain homogenate 
was insensitive to stigmatellin, an inhibitor of complex III. On the other hand, it is known that the level 
of mRNA (and protein) encoding SQR in the brain is very low [45]. Thus, it can be expected that a 
non-canonical pathway involving MetNgb plays the main role in H2S oxidation in the brain.  
5. Thiosulfate: From a Traditional Photographic Darkroom to Modern Medicine 
Thiosulfates are salts of unstable thiosulfuric acid (H2S2O3), of which the best known is sodium 
salt, i.e. sodium thiosulfate (STS, Na2S2O3). 
STS was widely used in traditional photography to fix black and white negatives and prints after 
the developing stage. This compound has long been known also to physicians and pharmacologists. 
Historically, it was used in the treatment of cyanide poisoning. Transformation of toxic cyanide to 
much less toxic thiocyanate (rhodanate) with the use of an outer sulfur atom of STS is catalyzed by TST. 
Figure 3. A schematic representation of the postulated mechanism for the etHb and
MetMb-dependen oxidation of H2S to thiosulfate and heme iron-boun persulfides. Modified from
Vitvitsky et al. [21] and Bostelaar et al. [38].
4. Interactions of Neuroglobin with Hydrogen Sulfide
Ngb is a member of the emoprotein family which is expressed in the brai , mostly in the subthalamic
nucleus, frontal lobe, thalamus and occipital pole [35]. Ngb was also identified in other tissues, such as
the gastrointestinal tract, lungs, some endocrine tissues, spinal cord, lymph nodes and in the peripheral
ervous system [39–41]. It has been demonstrated that Ngb is the third protein, besides Hb and Mb,
reversibly binding oxygen via the Fe2+ ion of the heme group in humans and other vertebrates [39,42].
Ngb is a six-coordinate hemoprotein, with the heme iron coordinated by two histidine residues.
In terms of physicochemical pro erties, Ngb shows a greater similarity to Mb because it is a monomer
with molecular weight of 17,000 Da composed of 151 amino acids and characterized by a high affinity
for oxygen (half saturation pressure, P50 = 1–2 mmHg at 37 ◦C) [42]. Hence, it can be concluded
that Ngb is analogous to Mb. However, Ngb shares little amino-acid sequence similarity with Mb
(<21% identity) [39]. Ngb displays also a modest sequence homology with Hb (<25% identity) [39].
The physiological role of Ngb is still elusive. Currently, it is assumed that Ngb is an endogenous
neuroprotective protein, active against several brain injuries, including hypoxia, ischemia, toxicity,
and oxygen/nutrient deprivation [43]. In vitro studies showed that H2S bound very tightly to the heme
group of human ferric Ngb (MetNgb). The bimolecular rate constant for H2S binding to MetNgb
was about 35 and 1000 fold slower than for MetHb and MetMb, respectively [30].
Ruetz et al. [44] observe that 2S oxi ation to s lfate and thiosulfate in the brain homogenate
was insensitive to stig atellin, an inhibitor of co plex III. n the other hand, it is known that the level
of mRNA (and protein) encoding SQR in the brain is very lo [45]. Thus, it can be expected that
a non-canonical pathway involving MetNgb plays the main role in H2S oxidation in the brain.
5. Thiosulfate: From a Traditional Photographic Darkr om to Modern Medicine
Thiosulfates are salts f aci (H2 2 3 , i the best known is odium
salt, i.e. sodium thiosulfate (STS, Na2S2O3).
STS was widely used in tra iti l fi lack and white negatives and prints after
the developing stage. This co pound s als to physicians and pharmacologists.
Historically, it as se tr t of cyanide poisoning. Transformation of toxic cyanide to
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much less toxic thiocyanate (rhodanate) with the use of an outer sulfur atom of STS is catalyzed by
TST. Thiocyanate is excreted by the kidneys. Cyanides are widespread as components of many plants
and can cause poisonings following ingestion of some plant products. However, small amounts of
cyanides are normally detoxified with the use of endogenous thiosulfate.
Bijarnia et al. observed a beneficial effect of STS in a chronic rat model of ethylene glycol
(EG)-induced hyperoxaluria. In particular, STS significantly reduced crystal load and preserved
creatinine clearance, tissue superoxide dismutase (SOD) and urine 8-isoprostaglandin levels. In vitro
studies showed the ability of STS to scavenge oxalate-induced reactive oxygen species (ROS),
to reduce cell-released hydrogen peroxide and to preserve SOD activity. According to those
authors’ opinion, antioxidant properties of STS were responsible for efficacy of this compound
in alleviating EG-induced hyperoxaluria in rats [46]. It has also been indicated that α-tocopherol and
STS supplementation during antibiotic therapy in patients with infiltrative pulmonary tuberculosis
allows for a considerable reduction of antibiotic load. The authors suggested also the antioxidant
properties of STS as the mechanism explaining this finding [47]. Thomas and McGinnis [48] reported
the safe co-administration of intrathecal sodium nitroprusside and STS in 10 patients with secured
ruptured cerebral aneurysms in the intensive care unit, without the use of cerebral angiography for
vasospasm treatment.
In the last decade, we have witnessed an increasing interest in STS as a drug in patients suffering
from calciphylaxis. Calciphylaxis was first described by Selye et al. [49]. This disease is characterized
by the accumulation of calcium deposits in small and medium blood vessels and ischemic and
necrotic changes in subcutaneous tissue and in the skin. This disease occurs mostly in end-stage
renal disease (ESRD) patients treated with dialysis (uremic calciphylaxis), however, there have been
cases described in patients with preserved renal function (non-uremic calciphylaxis). Risk factors
of vessel calcification are similar to those of atherosclerosis and include: obesity, hypertension,
hypertriglyceridemia, increased concentration of LDL cholesterol and reduced concentration of HDL
cholesterol. Calcification of vessels strongly correlates with prevalence of cardiovascular diseases
and is an important predictive factor of cardiovascular events, including ischemic heart disease also
with a fatal outcome [50]. In uremic rats, STS inhibited calcification in the heart and kidneys [51]
and prevented nephrolithiasis [52]. Clinically, STS was used to treat calciphylaxis and was reported
to reduce the mortality rate [53]. Many studies indicated that STS treatment caused quick pain
relief in patients and accelerated healing of necrotic changes in the skin [54–59]. Chen at al. clearly
demonstrated that STS directly inhibited high phosphorus-induced calcification in adipocytes but had
no effect on vascular smooth muscle cell calcification [60]. Hayden and Goldsmith [61] have suggested
that STS is a new hope for the treatment of calciphylaxis.
It should be reminded that the outer sulfur atom of thiosulfate exhibits properties characteristic of
sulfane sulfur and that thiosulfate is a stable, nontoxic metabolite of H2S. In addition, currently,
interrelations between the existing sulfur deposits in cells and endogenously produced H2S
are increasingly often indicated. The synthesized H2S can be stored in the form of sulfane sulfur and
can be released as needed by the cell. Sen et al. [62] demonstrated that STS can be considered for
therapeutic intervention in heart failure due to its ability to modulate endogenous H2S generation.
In addition, it was proven that H2S breathing in mice prevented inflammation and improved survival
after lipopolysaccharide (LPS) challenge, which was associated with increased plasma thiosulfate
level [63]. Sakaguchi et al. [64] showed that STS exerted robust anti-inflammatory effects in the mouse
lung and vascular endothelium.
It appears that biological actions initially attributed to H2S actually are effects of sulfane
sulfur compounds. Thus, it appears that rather thiosulfate which is a sulfane sulfur containing
compound, than H2S, is a signaling agent possessing regulatory effect in biological systems [65].
Mishanina et al. [66] have suggested that thiosulfate is a signaling molecule, belonging to reactive
sulfur species (RSS), which can be viewed as an ideal “Trojan horse”, because upon activation by
sulfurtransferases, it can mobilize its outer sulfur to transfer.
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Sulfane sulfur transfer to thiol groups of receptor and enzymatic proteins leads to the formation
of persulfides and/or trisulfides that often changes activity of these proteins. This is another, besides
S-thiolation and S-nitrosylation, mechanism of covalent modification of protein –SH groups [11].
The functions of sulfane sulfur include also posttranscriptional modification of transfer RNA (tRNA),
and synthesis of iron-sulfur center in iron-sulfur proteins and coenzymes, such as biotin, lipoic acid
and thiamine as well as involvement in antioxidant potential regulation [4].
6. Conclusions
Aerobic and anaerobic cysteine transformations are linked via formation and biodegradation of
thiosulfate. These processes occur in mitochondria and are regarded as a canonical H2S oxidation
pathway (Figure 1). However, lately new chemical interactions between H2S and hemoproteins have
been described, yielding also thiosulfate. This process was called a non-canonical H2S oxidation
pathway (Figure 3). Until recently, it appeared that the goal of thiosulfate production was only to delay
irreversible oxidation of H2S to sulfate excreted in urine. However, in the light of the newest data
presented in this review, it seems that thiosulfate is a molecule that plays a much more prominent role
in the human body (Figure 4).
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We hope that all these findings will inspire further studies on the role of hemoproteins in the 
processes implicated in the formation of this fascinating molecule, which undoubtedly thiosulfate is, 
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The data reviewed in this paper also change the traditional understanding of Hb and Mb function
as proteins engaged in binding, transport and storage of most of all oxygen molecule, and clearly
show that these hemoproteins are important players in the H2S homeostatic processes significantly
contributing to thiosulfate production. It is particularly important in RBCs which are devoid of
the canonical mitochondrial H2S oxidation pathw y, and thus in the whole circulatory system,
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ru ning in th cytoplasm. It also a pears that the n n-canonical H2S oxidation pathw y involving
Ngb is the main H2S oxidation route in the brain.
We hope that all these findings will inspire further studies on the role of hemoproteins
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is, and on the mechanisms responsible for its biological activity in the human body.
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actions of lipoic acid associated with sulfane sulfur metabolism. Pharmacol. Rep. 2008, 60, 225–232. [PubMed]
2. Iciek, M.; Bilska-Wilkosz, A.; Górny, M.; Sokołowska-Jeżewicz, M.; Kowalczyk-Pachel, D. The Effects of
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Acid as a Possible Pharmacological Source of Hydrogen Sulfide/Sulfane Sulfur. Molecules 2017, 22, 388.
[CrossRef] [PubMed]
6. Ogasawara, Y.; Isoda, S.; Tanabe, S. Tissue and subcellular distribution of bound and acid-labile sulfur, and
the enzymic capacity for sulfide production in the rat. Biol. Pharm. Bull. 1994, 17, 1535–1542. [CrossRef]
[PubMed]
7. Mikami, Y.; Shibuya, N.; Kimura, Y.; Nagahara, N.; Ogasawara, Y.; Kimura, H. Thioredoxin and dihydrolipoic
acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochem. J. 2011,
439, 479–485. [CrossRef] [PubMed]
8. Abe, K.; Kimura, H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci.
1996, 16, 1066–1071. [PubMed]
9. Bełtowski, J. Hydrogen sulfide in pharmacology and medicine—An update. Pharmacol. Rep. 2015, 67,
647–658. [CrossRef] [PubMed]
10. Wang, R.U.I. Two’s company, three’s a crowd: Can H2S be the third endogenous gaseous transmitter?
FASEB J. 2002, 16, 1792–1798. [CrossRef] [PubMed]
11. Iciek, M.; Kowalczyk-Pachel, D.; Bilska-Wilkosz, A.; Kwiecień, I.; Górny, M.; Włodek, L. S-sulfhydration as
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